Phreesia, Inc.

NYSE:PHR Stock Report

Market Cap: US$1.7b

Phreesia Management

Management criteria checks 2/4

Phreesia's CEO is Chaim Indig, appointed in Jan 2005, has a tenure of 20.08 years. total yearly compensation is $8.27M, comprised of 6% salary and 94% bonuses, including company stock and options. directly owns 2.37% of the company’s shares, worth $39.98M. The average tenure of the management team and the board of directors is 4.1 years and 17.3 years respectively.

Key information

Chaim Indig

Chief executive officer

US$8.3m

Total compensation

CEO salary percentage6.0%
CEO tenure20.1yrs
CEO ownership2.4%
Management average tenure4.1yrs
Board average tenure17.3yrs

Recent management updates

Recent updates

Phreesia, Inc.'s (NYSE:PHR) Shares Climb 27% But Its Business Is Yet to Catch Up

Dec 27
Phreesia, Inc.'s (NYSE:PHR) Shares Climb 27% But Its Business Is Yet to Catch Up

Phreesia Has Turned The Corner, Can It Continue To Mend?

Dec 12

Market Participants Recognise Phreesia, Inc.'s (NYSE:PHR) Revenues

Nov 07
Market Participants Recognise Phreesia, Inc.'s (NYSE:PHR) Revenues

Is Phreesia (NYSE:PHR) Weighed On By Its Debt Load?

Oct 08
Is Phreesia (NYSE:PHR) Weighed On By Its Debt Load?

Here's What Analysts Are Forecasting For Phreesia, Inc. (NYSE:PHR) After Its Second-Quarter Results

Sep 06
Here's What Analysts Are Forecasting For Phreesia, Inc. (NYSE:PHR) After Its Second-Quarter Results

Phreesia: Remain Bullish Given The Healthy Growth Outlook

Sep 05

Market Participants Recognise Phreesia, Inc.'s (NYSE:PHR) Revenues Pushing Shares 26% Higher

Jul 18
Market Participants Recognise Phreesia, Inc.'s (NYSE:PHR) Revenues Pushing Shares 26% Higher

Phreesia: Growth Remains Strong, With EBITDA Margin Set To Improve

Jun 06

The Price Is Right For Phreesia, Inc. (NYSE:PHR)

May 25
The Price Is Right For Phreesia, Inc. (NYSE:PHR)

Are Investors Undervaluing Phreesia, Inc. (NYSE:PHR) By 39%?

May 03
Are Investors Undervaluing Phreesia, Inc. (NYSE:PHR) By 39%?

At US$23.80, Is Phreesia, Inc. (NYSE:PHR) Worth Looking At Closely?

Apr 12
At US$23.80, Is Phreesia, Inc. (NYSE:PHR) Worth Looking At Closely?

Phreesia Continues To Stay Positive On The Business Growth

Apr 03

Phreesia: Healthcare Digitization Beneficiary Hampered By Valuation

Mar 01

Investors Still Waiting For A Pull Back In Phreesia, Inc. (NYSE:PHR)

Feb 16
Investors Still Waiting For A Pull Back In Phreesia, Inc. (NYSE:PHR)

Phreesia: Remain Buy Rated As The Business Pivot Towards Profitable Growth

Jan 04

Is Phreesia Finally Turning The Corner?

Dec 07

Does Phreesia (NYSE:PHR) Have A Healthy Balance Sheet?

Oct 25
Does Phreesia (NYSE:PHR) Have A Healthy Balance Sheet?

Phreesia: Share Price Dip Is A Buying Opportunity

Sep 21

Phreesia: Strong Execution Should Continue To Drive Growth

Jul 11

Phreesia, Inc.'s (NYSE:PHR) Share Price Matching Investor Opinion

May 18
Phreesia, Inc.'s (NYSE:PHR) Share Price Matching Investor Opinion

Phreesia: Strong Growth Momentum With Expanded TAM

Jan 28

Phreesia - Healthcare Ecosystem At An Attractive Valuation

Dec 13

Phreesia Q3 2023 Earnings Preview

Dec 07

Phreesia GAAP EPS of -$0.89 beats by $0.08, revenue of $67.9M beats by $2.15M

Sep 07

Phreesia: Their Time Has Passed

May 10

CEO Compensation Analysis

How has Chaim Indig's remuneration changed compared to Phreesia's earnings?
DateTotal CompensationSalaryCompany Earnings
Oct 31 2024n/an/a

-US$83m

Jul 31 2024n/an/a

-US$100m

Apr 30 2024n/an/a

-US$119m

Jan 31 2024US$8mUS$495k

-US$137m

Oct 31 2023n/an/a

-US$144m

Jul 31 2023n/an/a

-US$152m

Apr 30 2023n/an/a

-US$162m

Jan 31 2023US$8mUS$515k

-US$176m

Oct 31 2022n/an/a

-US$185m

Jul 31 2022n/an/a

-US$181m

Apr 30 2022n/an/a

-US$158m

Jan 31 2022US$9mUS$515k

-US$118m

Oct 31 2021n/an/a

-US$80m

Jul 31 2021n/an/a

-US$50m

Apr 30 2021n/an/a

-US$32m

Jan 31 2021US$6mUS$419k

-US$27m

Oct 31 2020n/an/a

-US$23m

Jul 31 2020n/an/a

-US$19m

Apr 30 2020n/an/a

-US$83m

Jan 31 2020US$10mUS$346k

-US$91m

Oct 31 2019n/an/a

-US$102m

Jul 31 2019n/an/a

-US$113m

Apr 30 2019n/an/a

-US$54m

Jan 31 2019US$510kUS$300k

-US$45m

Compensation vs Market: Chaim's total compensation ($USD8.27M) is above average for companies of similar size in the US market ($USD5.36M).

Compensation vs Earnings: Chaim's compensation has increased whilst the company is unprofitable.

CEO

Chaim Indig (44 yo)

20.1yrs

Tenure

US$8,273,307

Compensation

Mr. Chaim Indig co-founded Phreesia, Inc. in January 2005 and serves as Chief Executive Officer and Director since January 2005. Mr. Indig has helped to revolutionize the patient check-in experience. Under...

Leadership Team

NamePositionTenureCompensationOwnership
Chaim Indig
Co-Founder20.1yrsUS$8.27m2.37%
$ 40.0m
Evan Roberts
Co-Founder & COO20.1yrsUS$4.50m1.31%
$ 22.2m
Balaji Gandhi
Chief Financial Officer1.9yrsUS$5.91m0.25%
$ 4.2m
Allison Hoffman
General Counsel & Secretary4.5yrsUS$3.04m0.090%
$ 1.5m
David Linetsky
Senior Vice President of Life Sciences5.9yrsUS$4.47m0.41%
$ 6.9m
Yvonne Hui
VP & Principal Accounting Officerless than a yearno datano data
Jack Callahan
Chief Technology Officerless than a yearno datano data
Maureen McKinney
Vice President of Corporate Communications4.1yrsno datano data
Ashwin Uttamchandani
Vice President of Sales & Marketing Operationsno datano datano data
Amy VanDuyn
Senior Vice President of Human Resources14.8yrsno data0.20%
$ 3.3m
Hilary Hatch
Chief Clinical Officer3.8yrsno datano data
Melissa Mitchell
Chief Privacy Officer1.7yrsno datano data

4.1yrs

Average Tenure

45yo

Average Age

Experienced Management: PHR's management team is considered experienced (4.1 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Chaim Indig
Co-Founder20.1yrsUS$8.27m2.37%
$ 40.0m
Eve Kurtin
Board Observerno datano datano data
Edward Cahill
Independent Director17.3yrsUS$232.46k0.065%
$ 1.1m
Michael Weintraub
Independent Chairman20.1yrsUS$384.98k0.57%
$ 9.6m
Richard Jackson
Member of Medical Advisory Boardno datano datano data
Gillian Munson
Independent Director5.8yrsUS$257.46k0.018%
$ 296.3k
Elsa-Grace Giardina
Member of Medical Advisory Boardno datano datano data
Mark Blais
Member of Medical Advisory Boardno datano datano data
Michael Brodman
Member of Medical Advisory Boardno datano datano data
Lee Schwamm
Member of Medical Advisory Boardno datano datano data
Susan MacDonald
Member of Medical Advisory Boardno datano datano data
Mark Smith
Independent Director6.3yrsUS$244.98k0.011%
$ 177.2k

17.3yrs

Average Tenure

62yo

Average Age

Experienced Board: PHR's board of directors are seasoned and experienced ( 17.3 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/06 00:17
End of Day Share Price 2025/02/06 00:00
Earnings2024/10/31
Annual Earnings2024/01/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Phreesia, Inc. is covered by 24 analysts. 15 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Joseph VruwinkBaird
Zhilin LongBerenberg
Richard CloseCanaccord Genuity